Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
3.
AJNR Am J Neuroradiol ; 27(8): 1654-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16971607

RESUMO

Although transcutaneous ultrasound combined with fine-needle aspiration is often used as initial modality for evaluating superficial neck masses, its role in management of deep-seated neck masses is limited. Intraoral ultrasound and guided biopsy helps in obtaining tissue from deep-seated neck masses for an accurate histologic diagnosis, providing useful information in treatment planning. This article discusses the role of intraoral ultrasound and presents 3 cases in which biopsy of deep-seated neck masses under intraoral ultrasound guidance helped in diagnosis and management.


Assuntos
Biópsia por Agulha , Neoplasias Nasofaríngeas/diagnóstico por imagem , Neoplasias Nasofaríngeas/patologia , Recidiva Local de Neoplasia/diagnóstico por imagem , Recidiva Local de Neoplasia/patologia , Neoplasias Orofaríngeas/diagnóstico por imagem , Neoplasias Orofaríngeas/patologia , Neoplasias Faríngeas/diagnóstico por imagem , Neoplasias Faríngeas/patologia , Cirurgia Assistida por Computador , Ultrassonografia de Intervenção , Adenoma Pleomorfo/diagnóstico por imagem , Adenoma Pleomorfo/patologia , Adulto , Idoso de 80 Anos ou mais , Biópsia por Agulha/instrumentação , Carcinoma/diagnóstico por imagem , Carcinoma/patologia , Diagnóstico Diferencial , Infecções por Vírus Epstein-Barr/diagnóstico por imagem , Infecções por Vírus Epstein-Barr/patologia , Feminino , Humanos , Achados Incidentais , Metástase Linfática/patologia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Nasofaringe/diagnóstico por imagem , Nasofaringe/patologia , Neoplasias de Bainha Neural/diagnóstico por imagem , Neoplasias de Bainha Neural/patologia , Orofaringe/diagnóstico por imagem , Orofaringe/patologia , Faringe/diagnóstico por imagem , Faringe/patologia , Cirurgia Assistida por Computador/instrumentação , Ultrassonografia de Intervenção/instrumentação
4.
AJNR Am J Neuroradiol ; 27(6): 1288-91, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16775281

RESUMO

BACKGROUND: Endoscopic guided biopsy (EGB) is performed after an initial endoscopy for the investigation of patients with suspected nasopharyngeal carcinoma (NPC). The aim of the study was to determine whether MR imaging has the potential to replace invasive EGB in patients with a normal endoscopy. PATIENTS AND METHODS: Data from 2 groups of patients was reviewed, group 1 with proved NPC for MR staging (n = 456) and group 2 with suspected NPC (n = 77). The sensitivity was calculated for group 1 and sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for group 2. RESULTS: In group 1, which included 118 of 456 (26%) with stage 1 disease, cancer was detected in all patients, giving a sensitivity of 100%. In group 2, MR imaging was negative for NPC in 70 (91%) patients, and no cancer has been detected on follow-up (follow-up range, 1-90 months; mean, 36 months). MR imaging was positive for NPC in 7 (9%) patients and NPC was confirmed by biopsy in 3 (4%). Two of these 3 patients had undergone negative endoscopy and biopsy before the MR imaging. NPC was not present in the remaining 4 patients, 2 of whom were found to have lymphoid hyperplasia. MR imaging had a sensitivity of 100%, specificity of 95%, NPV of 100%, PPV of 43%, and accuracy of 95%. CONCLUSION: MR imaging has the potential to screen healthy patients who do not require EGB and direct the site of biopsy in small cancers that may be missed by endoscopy. On the basis of these results, a prospective study is planned.


Assuntos
Carcinoma/diagnóstico , Imageamento por Ressonância Magnética , Neoplasias Nasofaríngeas/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Carcinoma/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Nasofaríngeas/patologia , Nasofaringe/patologia , Sensibilidade e Especificidade
5.
Cancer Lett ; 205(1): 81-8, 2004 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-15036664

RESUMO

Human papillomavirus type 16 (HPV 16) plays an etiological role in human laryngeal carcinoma. Apoptosis is closely associated with various biological processes including oncogenesis. This study investigated how HPV 16 oncoproteins E6 and E7 affect apoptosis in human laryngeal cancer cells. We established two human laryngeal cancer cell lines that expressed HPV 16 E6 and E7, respectively. Using these two cell lines, we found that both E6 and E7 exhibited an inhibitive effect on apoptosis induced by tumor necrosis factor alpha and cycloheximide. In both transfected cell lines, the expression of pro-apoptotic Bak was reduced and that of anti-apoptotic Bcl-2 was over-expressed. However, the expression of caspase-3 and caspase-8 was not significantly different between the E6- and E7-transfected cells and the control cells without HPV 16. p53 Protein was not detected in either the transfected or the non-transfected cells. Our study indicates that: (1) HPV 16 E6 and E7 oncoproteins are capable of inhibiting apoptosis in laryngeal squamous carcinoma cells; (2) the mechanism modulated by E6 and E7 involves the over-expression of Bcl-2 and the down-regulation of Bak; (3) the anti-apoptotic pathway is not related to the level of p53, caspase-3, or caspase-8. These results suggest that the dysregulation of apoptotic molecules Bak and Bcl-2 by HPV 16 E6 and E7 plays a role in the prolongation of cell survival, which may subsequently contribute to the development of human laryngeal cancer.


Assuntos
Apoptose/fisiologia , Neoplasias Laríngeas/virologia , Papillomaviridae , Infecções por Papillomavirus/fisiopatologia , Proteínas Repressoras , Animais , Apoptose/efeitos dos fármacos , Western Blotting , Caspase 3 , Caspase 8 , Caspases/biossíntese , Caspases/efeitos dos fármacos , Linhagem Celular Tumoral , Cicloeximida/farmacologia , Humanos , Neoplasias Laríngeas/metabolismo , Proteínas de Membrana/biossíntese , Proteínas de Membrana/efeitos dos fármacos , Proteínas Oncogênicas Virais/genética , Proteínas E7 de Papillomavirus , Inibidores da Síntese de Proteínas/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Transfecção , Fator de Necrose Tumoral alfa/farmacologia , Proteína Supressora de Tumor p53/biossíntese , Proteína Supressora de Tumor p53/efeitos dos fármacos , Proteína Killer-Antagonista Homóloga a bcl-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA